French drugmaker Sanofi has made a $40 million investment in Gyroscope Therapeutics, with another $20 million potentially on offer as the UK biotech advances its clinical-stage gene therapies for ...
Gyroscope Therapeutics and its gene therapy for the sight-robbing disease geographic atrophy (GA) has been acquired by a big pharma company – but likely not the one you would expect. Just a few weeks ...
Connected devices are ubiquitous in our era of wireless chips heavily relying on streaming data to someone else’s servers. This sentence might already start to sound dodgy, and it doesn’t get better ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback